| Tiffany D Reabold, CRNP | |
|
910 Frederick Rd, Catonsville, MD 21228-4516 | |
| (410) 644-1880 | |
| (410) 646-3623 |
| Full Name | Tiffany D Reabold |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 21 Years |
| Location | 910 Frederick Rd, Catonsville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053392373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R137035 (Maryland) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R137035 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Emergency Medicine Associates Pa | 1951294941 | 45 |
News Archive
Avanir Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed a new patent that covers Avanir's product NUEDEXTA, further expanding the intellectual property portfolio for the company's lead commercial asset.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.
› Verified 7 days ago
| Entity Name | University Of Maryland Emergency Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144271743 PECOS PAC ID: 1951294941 Enrollment ID: O20040204000360 |
News Archive
Avanir Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed a new patent that covers Avanir's product NUEDEXTA, further expanding the intellectual property portfolio for the company's lead commercial asset.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.
› Verified 7 days ago
| Entity Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20130808000102 |
News Archive
Avanir Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed a new patent that covers Avanir's product NUEDEXTA, further expanding the intellectual property portfolio for the company's lead commercial asset.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.
› Verified 7 days ago
| Entity Name | University Of Maryland Midtown Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710347729 PECOS PAC ID: 1557640356 Enrollment ID: O20161118001423 |
News Archive
Avanir Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed a new patent that covers Avanir's product NUEDEXTA, further expanding the intellectual property portfolio for the company's lead commercial asset.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany D Reabold, CRNP 910 Frederick Rd, Catonsville, MD 21228-4516 Ph: (410) 644-1880 | Tiffany D Reabold, CRNP 910 Frederick Rd, Catonsville, MD 21228-4516 Ph: (410) 644-1880 |
News Archive
Avanir Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed a new patent that covers Avanir's product NUEDEXTA, further expanding the intellectual property portfolio for the company's lead commercial asset.
Daiichi Sankyo, Company Limited (hereafter, Daiichi Sankyo) today announced that the Marketing Authorization Application for its investigational, oral, once-daily direct factor Xa-inhibitor edoxaban has been submitted to the European Medicines Agency.
An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.
Reuters on a report from the Organisation for Economic Cooperation and Development: The increase in health spending is "piling pressure budgets already hit" by the recession and is "likely to continue rising as populations age, technology improves and public expectations grow. ... Given the urgent need to reduce their budget deficits, many OECD governments will have to make difficult choices to sustain their healthcare systems: curb the growth of public spending on health, cut spending in other areas, or raise taxes," according to the report.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.
› Verified 7 days ago
Mrs. Ija Lynn Delia, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 Maiden Choice Ln, Catonsville, MD 21228 Phone: 410-247-5602 Fax: 410-242-1756 | |
Joy C Odinammadu, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6400 Baltimore National Pike Ste 170a, Catonsville, MD 21228 Phone: 443-739-7947 | |
Belinda Okoruwa, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1000 Ingleside Ave, Catonsville, MD 21228 Phone: 443-551-3784 | |
Michele Kyle Bradshaw, Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 6120 Baltimore National Pike Ste 200, Catonsville, MD 21228 Phone: 301-291-5272 | |
Dr. Renada Lynn Gilliard, DNP, MS, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9 Turk Garth, Catonsville, MD 21228 Phone: 443-695-4433 | |
Assiatu B. Barrie, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 Maiden Choice Ln, Catonsville, MD 21228 Phone: 410-737-8838 |